Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC).
Chen Z. et al, (2005), Int J Epidemiol, 34, 1243 - 1249
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Abe O. et al, (2005), The Lancet, 366, 2087 - 2106
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
Chen ZM. et al, (2005), Lancet, 366, 1607 - 1621
Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
Chen ZM. et al, (2005), Lancet, 366, 1622 - 1632
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
Fibrinogen Studies Collaboration None. et al, (2005), JAMA, 294, 1799 - 1809
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis
Danesh J. et al, (2005), Journal of the American Medical Association, 294, 1799 - 1809
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Baigent C. et al, (2005), Lancet, 366, 1267 - 1278
Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women.
Magnusson CMK. et al, (2005), Br J Cancer, 93, 817 - 824
Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.
Homocysteine Lowering Trialists' Collaboration None., (2005), Am J Clin Nutr, 82, 806 - 812
Worldwide meta-analyses of breast cancer treatment - EBCTCG 2005 - an update
Peto R., (2005), EJC SUPPLEMENTS, 3, 3 - 3
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
Cogliano V. et al, (2005), Lancet Oncol, 6, 552 - 553
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
Darby SC. et al, (2005), Lancet Oncol, 6, 557 - 565
Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
Beral V. et al, (2005), BJOG, 112, 692 - 695
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Abe O. et al, (2005), Lancet, 365, 1687 - 1717
Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V. et al, (2005), Lancet, 365, 1543 - 1551
Reproducibility of a short semi-quantitative food group questionnaire and its performance in estimating nutrient intake compared with a 7-day diet diary in the Million Women Study.
Roddam AW. et al, (2005), Public Health Nutr, 8, 201 - 213
Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study.
Brewster DH. et al, (2005), J Epidemiol Community Health, 59, 283 - 287
The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
Heart Protection Study Collaborative Group None., (2005), BMC Med, 3